1302. Cefiderocol Population Pharmacokinetics and Probability of Target Attainment in Plasma and Epithelial Lining Fluid in Patients with Pneumonia, Bloodstream Infection/Sepsis, or Complicated Urinary Tract Infections

BACKGROUND: Cefiderocol (CFDC) is a novel siderophore cephalosporin with activity against a broad range of Gram-negative bacteria. The aim of this study was to perform population pharmacokinetic (PopPK) analysis and evaluate probability of target attainment (PTA) in plasma and epithelial lining flui...

Descripción completa

Detalles Bibliográficos
Autores principales: Katsube, Takayuki, Kawaguchi, Nao, Echols, Roger, Wajima, Toshihiro, Nicolau, David P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776389/
http://dx.doi.org/10.1093/ofid/ofaa439.1485

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776389/
http://dx.doi.org/10.1093/ofid/ofaa439.1485

Ejemplares similares